Currently Viewing:
The International Society for Pharmacoeconomics and Outcomes Research
Continuing Forward With Innovation and Progress in US Healthcare
May 22, 2017
Dr Gail Wilensky: Senate Health Bill Will Be to the Left of the House
May 22, 2017
Accounting for Stakeholder Preferences in Value Assessments
May 22, 2017
Dr David M. Cutler Highlights the Importance of Reauthorizing the CHIP Program
May 22, 2017
Negotiating Successful Outcomes-Based Contracts
May 23, 2017
Dr Ilene Hollin: Tailored Approach to Value Assessment Is Necessary
May 23, 2017
Influencing Untreated Individuals Through Their Social Networks
May 23, 2017
Dr Steve Pearson Outlines the Importance of Thresholds on Determining Value
May 23, 2017
The Realities and Challenges of Medicare Negotiating Drug Prices
May 24, 2017
Dr Patricia Danzon: Cost-Effectiveness Thresholds Create Incentive to Develop Better Drugs
May 24, 2017
Gene Therapies Present Great Potential, but Also Ethical and Practicality Challenges
May 24, 2017
Dr James D. Chambers Talks Future Health Economics Trends He Is Watching
May 24, 2017
Dr Gail Wilensky Remains "Hopeful" for Bipartisan Legislation on Healthcare Reform
May 29, 2017
Currently Reading
Dr David Cutler: Won't Be Easy for Senate Republicans to Create a Healthcare Bill
May 30, 2017
Dr Steve Pearson's Outlook on the Ongoing Updates to ICER's Value Framework
June 18, 2017
Dr Scott Ramsey on Challenges of Determining Cost Effectiveness of Novel Cancer Treatments
June 19, 2017
Dr David Cutler Discusses Opportunities for Bipartisan ACA Reform
June 20, 2017
Dr Steve Pearson Explains How ICER Price Benchmarks Align Cost With Patient Benefits
June 22, 2017
Dr Gail Wilensky Raises Questions About Medicaid's Matching Grant Structure
June 25, 2017
Dr Scott Ramsey Addresses the Need for Differential Pricing Structures for Drugs
July 02, 2017
Dr Steve Pearson: Patient Perspectives Guide ICER Value Framework Development
July 04, 2017
Dr Gail Wilensky on the Likelihood of Continuing Value-Based Reimbursement Demonstrations
July 06, 2017
Dr David Cutler: Trump Administration's Attention Not on Value-Based Purchasing
July 09, 2017
Dr Steve Pearson on Data Needed to Evaluate Clinical and Economic Effects of New Therapies
July 14, 2017

Dr David Cutler: Won't Be Easy for Senate Republicans to Create a Healthcare Bill

Senate Republicans are faced with a tall task to create a healthcare bill that repeals the Affordable Care Act because they've made conflicting promises. According to David. M. Cutler, PhD, of Harvard University, Senate Republicans have set themselves up for a situation where they can't meet all of their promises.


Senate Republicans are faced with a tall task to create a healthcare bill that repeals the Affordable Care Act because they've made conflicting promises. According to David. M. Cutler, PhD, of Harvard University, Senate Republicans have set themselves up for a situation where they can't meet all of their promises.

Transcript

I think there are a couple of paths. One path is that the Senate may not pass anything, and this is probably my best guess because the Republicans have really made 2 conflicting promises. So the first promise they made was to the right wing of the Republican Party, where they said, “We will repeal the Affordable Care Act and along with doing that, we will get rid of the taxes on high-income people that were used to pay for medical care. So we’re going to repeal it and we’re going to cut the taxes to cut the money.” And then for middle-income Americans, they said, “Don’t worry, you’re going to get more care, better care, cheaper care.” But you’ve taken away the money, so more care, better care, cheaper care means you’re going to put in more money, but they’ve taken away a bunch of the money.

So they have now made completely conflicting promises: on the one hand you won’t have to pay in, on the other hand, you’re going to get better. There is no way to reconcile those without some magic happening somewhere. And so what you’re seeing is they’re trying to go around and figure, “Well, you know let’s cut Medicaid, but oh let’s do that in a way that doesn’t have people become uninsured; let’s cut the subsidies, but oh we can’t do that without people deciding not to take it up."

So I don’t think they can meet those promises—they can’t, as a matter of arithmetic, meet those promises. And so what they do then is really up in the air. Do they say, “You know what, we’re going to go to the right wing and say this is what you’ve wanted, screw middle America, we’re going to do what you want.” In which case, they’ll pass something with 20% support. Or are they going to say, “You know what, we couldn’t do this, so therefore we’re just not going to do anything.”

I’m not a great prognosticator, but I don’t think it’s going to be easy for them to come up with something. 

 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up